FINWIRES · TerminalLIVE
FINWIRES

Nine Entertainment、第3四半期のテレビ事業の総収益が1桁台前半の伸びにとどまり、第4四半期も低調なスタート

By

-- Nine Entertainment (ASX:NEC)は、火曜日にオーストラリア証券取引所に提出した書類の中で、2025年度第3四半期のテレビ事業の総収益が、前年同期比で一桁台前半の成長を記録したと発表した。

同社は、第4四半期は、短期的な市場全体の状況と、4月に収益を押し上げた連邦選挙の影響を反映し、やや低調なスタートを切ったと述べた。

Nine Entertainment は、継続事業ベースで、2025年度のテレビ事業の総コストが、QMSからの高収益を統合した上で、前年同期比で一桁台半ばから後半の減少になると予想している、と提出書類には付け加えた。

Stanについては、上半期の好調な勢いが継続し、下半期もEBITDA(金利・税金・減価償却費控除前利益)の力強い成長が見込まれるとナインは予想している。また、Nine Publishing は、第3四半期のデジタル購読料収入が15%増加し、第4四半期も好調な勢いが続くと、提出書類には記されている。同社の株価は、直近の火曜日の取引で1%上昇した。

Related Articles

Asia

Hong Kong Stocks Slump As Middle East Fighting Escalates

Hong Kong equities fell Tuesday as bearish sentiment prevailed amid escalating tensions in the Middle East.The Hang Seng Index fell by around 197.27 points, or roughly 0.8%, to end at 25,898.61, while the Hang Seng China Enterprises Index decreased by 43.90 points, or around 0.5%, to close at 8,730.49.Fighting in the Middle East resumed as the U.S. and Iran vied for control of the critical Strait of Hormuz, after U.S. President Donald Trump said Washington would help ships stranded in the waterway, a key route that carried about one-fifth of global oil and LNG trade before the war.Iran had previously warned it would view any such action as a violation of a previously agreed ceasefire.The Middle East conflict will hit many Asia-Pacific corporate sectors through oil price hikes, shipping and supply chain disruptions, dampened demand, and delayed cyclical rebounds, Fitch Ratings said in a recent release.In corporate news, two firms filed to go public in Hong Kong.Metis TechBio (HKG:7666) is seeking to raise about HK$2.11 billion via the sale of 201.2 million shares at HK$10.50 per share. The Chinese AI-driven nanotechnology company will use funds to further research and development of AI infrastructure.Meanwhile, Impact Therapeutics (HKG:7630) launched its IPO to raise HK$913 million via the sale of 42 million shares at an indicative maximum price of HK$21.75 per share. The China-based biotechnology firm will use proceeds mainly to fund clinical development.Elsewhere, Star Sports Medicine (HKG:1609) had a stellar debut in Hong Kong. The medical device company's shares closed at HK$215 per share on their first day of trading, 118% above the offer price of HK$98.50.

$^HSI$HKG:1609$HKG:7630$HKG:7666
Equities

Equinor Starts Production at Eirin Gas Field in North Sea

Equinor (EQNR) said Tuesday the Eirin field has begun production, exporting gas to Europe via the Gina Krog platform and Sleipner A platform.The company said the subsea project, developed on a fast timeline, is expected to deliver about 27.6 million barrels of oil equivalent, mostly gas.The development cost about 4.5 billion Norwegian Krone ($485.7 million) and is expected to extend the life of the Gina Krog field to 2036, the company said.Equinor said the project uses existing infrastructure and electrification, resulting in relatively low emissions of around 3 kg of CO2 per barrel produced.

$EQNR
US Markets

Indonesia Economy Expands By 5.61% on Year in First Quarter

Boosted in part by government outlays, Indonesia's gross domestic product (GDP) expanded by 5.61% on year in the first quarter, reported the Central Statistics Agency on Tuesday.Southeast Asia's largest economy logged the biggest annual expansion since 2022, but some experts warned the growth could lag in coming seasons as the national government tempers outlays, and as higher energy bills sap businesses and consumers.Government outlays rose 21.8% on year in the first quarter as Jakarta ramped up flagship social-welfare programs, including a free-meal scheme and village cooperative funding, to spur household consumption.The national government also spent briskly during the first quarter to support outlays during the fasting month of Ramadan, and the Eid al-Fitr holiday, when many businesses are closed.Despite challenges, the Indonesian economy may still grow by a relatively robust 5% for the full 2026 year, said economists with Maybank (Malayan Banking Berhad), which is Malaysia's largest bank.Headwinds to Indonesian economic growth are likely to intensify in the second quarter, with exports hampered by cost pressures on international trade, said Brian Lee and Hak Bin Chua, analysts at Maybank, reported the Singapore-based The Business Times.Higher fuel prices and a weakening Indonesian currency, the rupiah, are likely to push up import bills going forward, added the analysts.There are also concerns that Indonesian national government is engaged in unsustainable spending."A team of economists from the Macroeconomic, Finance and Political Economy Research Group at University of Indonesia noted that the government is continuing to roll out fiscally costly flagship programs, including a nationwide free-meal initiative," reported The Business Times.Concerns over fiscal outlays and government borrowing have also unsettled financial markets, including negative comments from credit-rating agencies Moody's and S&P Global Ratings, noted The Business Times.In Mid-April, S&P Global assigned a "BBB/A-2" rating to Indonesian bonds, with BBB- being the lowest rating for an "investment grade" government bond.If Indonesia national debt levels continue to rise, the BBB rating could be lowered, said S&P Global.

$^KLSE